You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 4,710,462


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,710,462
Title: Cell proliferation inhibitor and method of preparation
Abstract:This invention comprises preparing a cell proliferation inhibitor by a nonextractive method from a tissue which has neither a high content of collagen, nor proteoglycans. The source of inhibitor comprises hyalocyte cells, which release the inhibitor into culture medium. The inhibitor is isolated from the culture medium. By chromatographic separation fractions are provided of varying molecular weight. Fractions both below and above a molecular weight of about 13,000 daltons show inhibitory activity.
Inventor(s): Jacobson; Bernard (Lexington, MA)
Assignee: Boston Biomedical Research Institute (Boston, MA)
Application Number:06/828,874
Patent Claims:1. A non-extractive method for preparing an inhibitor of cell growth, comprising directly liquefying vitreous gel in the absence of extraction solvent by application of shear forces to the gel so as to directly covert the gel into a liquid, incubating said liquid with collagenase to reduce its viscosity, separating hyalocytes from said collagenase-treated liquid, incubating said hyalocytes in a culture medium, separating said hyalocytes from the medium, chromatographically separating said medium into several fractions of varying molecular weight, and isolating from at least one of said fractions a product having cell growth inhibitory activity.

2. The method of claim 1 wherein the direct liquefaction is accomplished by forcing the gel through a small orifice.

3. The method of claim 1 wherein the direct liquefaction is accomplished by application of sonic vibrations.

4. The method of claim 1 wherein the product is isolated from a fraction having a molecular weight of less than approximately 13,000 daltons.

5. The method of claim 1 wherein the product is isolated from a fraction having a molecular weight in excess of approximately 13,000 daltons.

6. A high molecular weight inhibitor of cell growth made by the method of claim 5.

7. The method of claim 1 wherein said step of chromatographically separating is accomplished on Bio-Gel P-10.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.